Collects experimental supported associations between biomolecules (miRNAs, metabolites, small molecules/drugs) and metabolic diseases. BioM2MetDisease provides detailed information including biomolecule and metabolic disease names, species, experimental techniques, experimental tissue, dysregulation patterns, etc. to describe how a biomolecule is related to metabolic disease. It also offers PubChem Compound Identifier (CID) for metabolites and small molecules/drugs, miRBase accession for miRNAs, Disease Ontology (DO) identifier and International Classification of Diseases (ICD-10) for metabolic diseases.
College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, China
BioM2MetDisease funding source(s)
Supported by The National Program on Key Basic Research Project [973 Program, Grant Nos. 2014CB910504], the National High Technology Research and Development Program of China [863 Program, Grant Nos. 2014AA021102], the National Natural Science Foundation of China [Grant Nos. 91439117, 61473106, 31501074, and 61603116].